&w=3840&q=100)
Maharashtra FDA revokes Zepto's food biz licence in Dharavi, Mumbai
During an inspection, the agency observed fungal growth on certain food articles, improper maintenance of cold storage temperatures, no clear separation between expired and valid stock, food products stored directly on the ground, wet and dirty floors, and the storage of food items near clogged and stagnant water. The inspection was carried out following information received from the Minister of State for FDA Yogen Kadam.
According to the authority, Kiranakart Technologies—the firm that operates Zepto—was found in violation of the Food Safety and Standards Act (2006) and the Food Safety and Standards (Licensing and Registration of Food Businesses) Regulations, 2011. 'The findings constitute a failure to comply with the conditions of the licence. Accordingly, Anupamaa Balasaheb Patil, assistant commissioner (food), ordered an immediate suspension under Section 32(3) of the Food Safety and Standards Act, 2006, and Regulation 2.1.8(4) of the Licensing and Registration Regulations, 2011,' the authority said in a statement.
The suspension will remain in effect until the establishment achieves full compliance and receives clearance from the licensing authority, the FDA added.
Responding to Business Standard's queries, a Zepto spokesperson said, 'At Zepto, maintaining the highest standards of food safety and hygiene is non-negotiable. We have already initiated an internal review and are working closely with the concerned authorities to ensure full and swift compliance. We are committed to rectifying the lapses identified and strengthening our processes to provide the best and safest quality of products to our consumers. We are taking all necessary corrective measures to resume operations in accordance with regulatory obligations and applicable laws at the earliest.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
2 hours ago
- Mint
FSSAI suspends AR Dairy's licence for ghee over adulteration and false information
New Delhi: The Food Safety and Standards Authority of India (FSSAI) has suspended the license of A.R. Dairy Food Pvt. Ltd, based in Dindigul, Tamil Nadu, for manufacturing, transporting, and selling ghee. The suspension, effective from 13 June 2025, follows a detailed investigation into serious violations, according to a person in the know and documents seen byMint. Based on the provisions of the Food Safety and Standards (FSS) Act, 2006, A.R. Dairy and its representatives could face a range of severe penalties like heavy monetary fines, imprisonment, and blacklisting. The company allegedly supplied adulterated ghee to Tirumala Tirupati Devasthanams (TTD), with potential foreign fats action comes after a previous suspension order from 14 February 2025, which was set aside by the Madurai Bench of the Madras High Court, which directed FSSAI to conduct a personal hearing. Multiple tests, such as gas-liquid chromatography (GLC) and high-performance liquid chromatography (HPLC), were performed as per the Food Safety Standards Act to check for ghee adulteration. These tests analyze the ghee's fatty acid profile. The presence of plant-based compounds like β-sitosterol, which are not found in pure milk fat, confirms adulteration. Tirumala Tirupati Devasthanams trust manages the operations and finances of the Venkateswara Temple in Tirumala, and is one of the most visited religious centres globally. The FSSAI's decision follows a previous suspension order from 14 February 2025, which was set aside by the Madurai Bench of the Madras High Court. The court had directed the FSSAI to give the company a personal hearing before issuing a new decision. Following this directive, a hearing was held on 3 June 2025, where A.R. Dairy Food representatives failed to provide satisfactory explanations or documentary evidence to FSSAI's Designated Officer addressing these allegations. The FSSAI cited several serious contraventions. First, the company was found to be selling and distributing ghee to TTD without a proper license for repackaging or relabeling. The company was not licensed for this activity. Second, the dairy provided false information to both FSSAI and TTD, claiming that the ghee was manufactured at their Dindigul facility. In reality, the ghee was procured from another firm, Sri Vyshnavi Dairy Specialties in Andhra Pradesh. During the personal hearing, company representatives admitted there was no written agreement with Sri Vyshnavi Dairy, stating the arrangement was made in "good faith". They also could not provide information about the traceability of four lots of ghee that were rejected by TTD and returned to Sri Vyshnavi Dairy. Queries sent to the Union health secretary, health ministry spokesperson, FSSAI headquarters in New Delhi, FSSAI's Southern Regional Office in Chennai, Central Bureau of Investigation and A.R. Dairy remained unanswered till press time. TTD and Sri Vyshnavi Dairy could not be contacted. The FSSAI noted this was a violation, as the company failed to report the rejection of the supplied ghee to the food authority. The suspension order, seen byMint, stated that the Designated Officer concluded that the company's submissions did not clear them of the violations. The FSSAI stated that the company appeared to have the intention of deceiving consumers and manipulating the process by providing false information. The FSSAI highlighted a major discrepancy between A.R. Dairy's declared production and the quantity supplied to TTD. According to annual returns, the company produced 14.15 MT of ghee in 2021-22 and 155 MT in 2023-24. Yet, the tender agreement required them to supply 850 MT over six months—far exceeding their reported capacity. The Central Bureau of Investigation (CBI) is still investigating the matter. 'The case serves as a warning to other food businesses that such violations will not be tolerated, protecting consumers from potentially adulterated products and false information,' the person familiar with the matter said, requesting anonymity. The FSSAI ensures food safety through regular, risk-based inspections and random sampling of food products. Both the central and state food safety departments conduct these checks to ensure compliance with quality and safety standards.
Mint
6 hours ago
- Mint
Ghost prescriptions, dark stores: Why quick delivery of medicine has become a headache
Quick-commerce medicine delivery is heating up, with Zepto recently joining Blinkit and Swiggy Instamart in the race. But as the space gets crowded, concerns are mounting over prescription-only medicines without proper checks. Industry body All India Organisation of Chemists and Druggists (AIOCD) has called for regulatory scrutiny and tighter oversight. 'Medicines are not groceries that should be delivered within 10 minutes. These are highly regulated and need utmost care while handling — something that can't always be assured in a dark-store model," said Rajiv Singhal, General Secretary, AIOCD. On 13 August, the association wrote to the home affairs ministry stating that easy access through online quick-commerce delivery has led to a sharp rise in misuse, including of Schedule H drugs such as Pregabalin, used for neuropathic pain, epilepsy, and anxiety. It alleged that medicines are being issued online without genuine prescription verification, raising concerns about 'ghost prescriptions" — fake or fabricated prescriptions used to procure restricted drugs. The same day, Zepto announced its entry into pharma, offering medicine delivery within 10 minutes across metropolitan cities, according to its press release. Prior to this, Swiggy had entered the segment in August 2024, launching its 'Instamart' grocery service—which included medicines in select markets—through a partnership with PharmEasy that operated as a shop-in-shop inside dark stores in Bengaluru. Blinkit last month introduced 10-minute delivery across its dark-store network and later piloted prescription-medicine delivery (including antibiotics, eye drops, antihistamines, and skin treatments) in Bengaluru. Blinkit has entered deeper into healthcare by piloting a 10-minute ambulance service in Gurugram. Queries sent to all three companies on 13 August did not elicit a response until press time. 'If platforms commit to only e-prescriptions issued and signed by registered doctors, run an automatic check against the National Medical Register, and keep a pharmacist in the loop before dispatch, leakage can be driven close to zero—even with fast delivery," said Nilaya Varma, co-founder at Primus Partners, a management consultancy firm in Delhi. Prescription verification still murky Prescription verification for Schedule H/H1/X drugs on quick-commerce is a legal mandate, not a best-efforts standard, said Aditya Patni, Partner at Khaitan & Co. Schedule H includes prescription-only drugs like antibiotics and anti-epileptics, dispensed by pharmacists without mandatory record-keeping. Schedule H1 adds stricter control—requiring prescriptions and three years of records for abuse-prone drugs. Schedule X is the most stringent, mandating duplicate prescriptions ((two copies of the doctor's prescription), special licences, and secure storage for narcotics and psychotropics. India still lacks a clear e-pharmacy rulebook; the draft regulations were never finalised. Platforms operate under older statutes like the Drugs & Cosmetics Act, 1940 and the Pharmacy Act, 1948, which never envisaged online prescription verification or instant delivery. Draft e-pharmacy rules, 2018—requiring licensed premises, pharmacist verification, and prescription uploads—remain unnotified. "This has left a regulatory vacuum, with enforcement fragmented among state drug inspectors," said Rishabh Gandhi, founder, Rishabh Gandhi and Advocate. Many platforms leverage the 'marketplace' model — which merely connects registered pharmacies to customers — to distance themselves from liability, even while facilitating the sale of prescription-only medicines, said Patni. 'Since they act as 'intermediaries' or 'aggregators' under the Information Technology Act, 2000, they do not require a licence for sale of drugs as the actual dispensation happens through physical pharmacies which are already registered," he said, adding that quick-commerce models — which rely on dark stores — may blur this line, leading to unlicensed storage and distribution. Moreover, 'JPEG prescriptions'—photos of paper scripts—are easy to forge, reuse, or edit, said Varma. 'The last mile is often not a licensed premise with a pharmacist on record, even though the Drugs & Cosmetics Rules mandate pharmacist supervision for retail supply. In addition, catalogue mis-tags (H/H1/X drugs flagged as regular SKUs) can let restricted medicines slip past controls," he added. Regulatory concerns circle established players too. Patni notes that in February 2023, the Central Drugs Standard Control Organisation (CDSCO) issued show-cause notices to 20 e-pharmacies—including Tata 1mg, Amazon, Flipkart, and Netmeds—for allegedly selling drugs without valid licenses or prescriptions. These entities claimed intermediary status. The Delhi high court had imposed an interim ban on unlicensed e-pharmacy operations in December 2018, and in March 2024 specifically directed the health ministry to finalise a policy on online sale of drugs. Licensed pharmacies can still sell online, but with the March 2024 deadline missed, the e-pharmacy legal framework remains unclear and enforcement patchy. Pregabalin predicament Meanwhile, Pregabalin has been a flashpoint recently—its rising misuse triggered the Drugs Technical Advisory Board (DTAB) to recommend moving it from Schedule H to H1, highlighting gaps in verification and enforcement. Pregabalin can only be sold on a doctor's prescription with record-keeping and labelling compliance. Some states such as Punjab have even tightened controls on high-dose formulations and bulk sales to curb misuse and diversion. In April 2025, the DTAB recommended reclassifying pregabalin and its formulations under Schedule H1, but the change awaits a gazette notification to take legal effect. While regulators and chemist bodies flag the broader system risk, all Schedule H, H1, and X drugs—including antibiotics, opioids, and psychotropics—can be misused if prescription verification is weak, enabling diversion and unsafe consumption. "Traditional pharmacies sometimes dispense medications without strict prescription checks, especially if they know the patient personally. A physical pharmacy isn't going anywhere, so such practices are easier to trace, but with e-pharmacies, it's much harder to monitor or track, which is why the scrutiny often feels uneven," said Dr. Chitra Raju, a general practitioner in Delhi. That said, quick commerce and e-pharmacy can improve healthcare for chronic patients and expand access, particularly for the elderly and in high-traffic urban areas, said Varma of Primus Partners. 'E-pharmacies already serve 20,000+ pincodes, and quick-commerce pharmacy networks have penetration access to 100+ cities. For an ageing India—10.5% of the population is 60+, projected to reach 20.8% by 2050—reliable refills and doorstep delivery can reduce drop-offs for long-term therapies," he added. India's e-pharmacy market has around 50 players and was valued at $0.5 billion in 2019 (~2–3% of total pharmacy sales), projected to grow to $4.5 billion by 2025 at a CAGR of 44%. Major players like PharmEasy, Tata 1mg, Netmeds, and Medlife combine medicine delivery with services such as doctor consultations and lab tests, according to India Brand Equity Foundation (IBEF) under the commerce ministry.
Mint
9 hours ago
- Mint
Zepto surprises customer with empty Amul butter box on Janmashtami: Social media hails 'cool marketing'
Zepto came up with a clever marketing strategy on Janmashtami. The quick-commerce food delivery platform found an interesting way to sell butter on Krishn Janmashtami by sending empty butter boxes with a heartfelt note. A Reddit user pointed to this clever marketing strategy on Krishna Janmashtami. The annual Hindu festival that celebrates the birth of Krishna with great fervour and enthusiasm was observed on August 16 this year. According to religious beliefs, Krishna is famously and playfully referred to as "Maakhan Chor" or butter stealer. Through a jaunty and symbolic reference to the deity on the auspicious occasion of birth anniversary of the eighth avatar of Vishnu, Zepto incorporated this marketing move to advertise Amul's butter. Zepto sent empty butter boxes with a humorous note referencing Krishna on Janmashtami. The heartfelt note, "Oops, Maakhan chor got here before you! Amul butter delivered in 10 minutes gone in seconds" accompanying the butter boxes surprised customers. The other side of the card wishes 'Happy Janmashtami.' The caption to the viral post states, 'Zepto is sending Free empty Amul butter boxes on Janmashtmi. How many of you agree that Blinkit does better marketing? Or instamart?' This Reddit post amassed over 2.2 thousand reactions within 21 hours. A string of reactions poured on social media after this unique approach caught social media attention. A user inquired, 'What did they do with the actual contents?' A second user wrote, 'Zepto cafe wale samaan m use kr liya.' Another user remarked, 'The box doesn't have oily patches either true, this is a creative one!' A fourth comment read, 'It's pretty smart, tbh. Don't think we need to unnecessarily critique everything.' A fifth user wrote, 'It's such cool marketing!' A sixth user stated, 'Lol. It took me a while to understand the reference to Krishna's butter stealing incident. What a clever and funny ad!' A seventh user said, 'Janmashtmi p April fool bna rahe hain.' A user on X wrote, 'Ordered from Zepto and found an empty butter packet with this note inside. Smooth marketing!'
